Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
ORCID: 0000-0002-3116-912XAlso affiliated with Instituto Nacional de Cancerología
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 5 papers. Top paper: “Nivolumab plus cabozantinib versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended follow-up from the phase III randomised CheckMate 9ER trial”.
Mauricio Burotto, Bernard Escudier, Andrea B. Apolo, María T. Bourlon, Amishi Y. Shah +15 more
Bernard Escudier, Mauricio Burotto, Thomas Powles, Andrea B. Apolo, María T. Bourlon +16 more
Monica M. Laronda, Madison Q. Gowett, K. Trotter, Hannah Anvari, F. Fei +42 more
María T. Bourlon, José Luis Rodríguez-Olivares, Luis Orozco, Deborah Bazua, Andrés Rodríguez-Faure +6 more
Linsey Eldridge, Douglas M. Puricelli Perin, Yelena Shnayder, Rahma Mkuu, Rose Anorlu +6 more